CTX-M ESBLs have been increasingly reported from human enterobacteria isolates in 26 Tunisia. NDM-1 carbapenemase was recently reported in isolates from Tunisian Hospitals. 27 During a 2-month period (December 2017 to January 2018), we have collected 23 ESBL- 28 producing Enterobacteriaceae (ESBL-E) from urines of patients hospitalized in three health 29 care facilities and from community, situated in two distinct Tunisian geographical regions. 30 They were divided into 15 Escherichia coli and eight Klebsiella pneumoniae. The aim of this 31 study was to characterize ESBL-E with regard to their β-lactamase content and their 32 epidemiological relationship. The results indicated a high rate (47%) of E. coli producing both 33 CTX-M group-1 and -9. For the first time, we demonstrated the presence of E. coli having 34 concomitantly CTX-M-15 and CTX-M-27 which belong to two sequences types (ST), ie. A-35 ST617 (2 isolates) and B2-ST131 subclade C2 (2 isolates). All four E. coli isolates carried a 36 multireplicon IncF with an identical allelic combination, F31:A4:B1. This study reports also 37 the first description of K. pneumoniae belonging to the clone ST147 carrying the 38 carbapenemase NDM-1 in the Tunisian community. In conclusion, our data confirms the need 39 for monitoring the resistance to extended-spectrum cephalosporins and to carbapenems 40 among enterobacteria in Tunisia. 41 42 43
INTRODUCTION
by the groups A (33.3%), B1 (20%) and D (6.7%) ( Table 2) . Considering a cluster defined at 126 a 68% similarity level (13), the 15 E. coli were assigned to 11 distinct PFGE patterns 127 (pulsotypes E-1 to E-11, Figure 1 and Table 2 ). Four isolates of subgroup B2 divided into a 128 similar pulsotype E-1 (ID# 35SR; 17J, 17MA and 151, Figure 1, lanes 1 to 4) and two isolates 129 of subgroup A (ID# 917 and 46SR) exhibited an identical profile E-2. To point out the 130 phylogenetic relationship of the six strains, MLST typing were performed and showed that the 131 two isolates of E-2 profile can be including in the sequence type A-ST617 and the four E-1 132 profile belonged to the clone B2-ST131 (Table 2) . Among the four later isolates, two carried a All ESBL-producing E. coli strains showed decreased susceptibility to ß-lactams, except to 147 cephamycins (ie. cefoxitin) and carbapenems. All remained susceptible to fosfomycin, and 148 two isolates were resistant to nitrofurantoin ( Table 2) . All E. coli were resistant to co-149 trimoxazole (sulfamethoxazole-trimethoprim) and all, except two isolates of phylogenetic 150 groups B1 and D, were resistant to fluoroquinolones (Table 2) . They exhibited different 151 aminoglycoside phenotypes (resistance to gentamicin, tobramycin and amikacin, 26%, 47% 152 and 20%, respectively) ( Table 2) . Among the K. pneumoniae strains, they exhibited various 153 profiles to tested antibiotics (Table 3) . A single isolate (ID# 18TA) with the NDM-1 enzyme 154 showed a diminution of diameter to imipenem which was restored by addition of EDTA.
155
Plasmids of E. coli were characterized by PCR-based replicon typing (15). Most of them were 156 assigned to a multi-replicon replicon IncFII (Table 2) . A sub-typing scheme of this replicon 157 using a FAB formula (FII:FIA:FIB) was performed for the six E. coli isolates of pulsotypes E-158 1 and E-2. Thus, four E. coli including the two isolates of pulsotype E-2 and two other ones 159 (E-1) ascribed to lineages A-ST617 and B2-ST131-C2, respectively harbored the formula 160 replicon: F31:A4:B1 (Table 2) . Other plasmids were also found in these epidemic isolates, ie. The presence of CTX-M ESBLs and of carbapenemases such as NDM-1 from human 169 enterobacteria isolates has been increasingly reported worldwide, including Tunisia. (1, 11, 170 16). In this 2-month survey, the incidence rate of ESBL-producing Enterobacteriaceae from 171 urine collected from patients hospitalized in three health care facilities from two geographical 172 areas of Tunisia, ranged from 11.1% to 3.7%. Data are consistent with those described in variants without this substitution (21, 22); suggesting than a high ceftazidime selection 186 pressure could favor the emergence of such isolates. Thus, we report the presence of the two 187 enzymes in at least four fluoroquinolone-resistant E. coli isolates belonging to two different 188 STs. Two of them were associated to the pandemic and virulent clone ST131, belonging to 189 the phylogenetic group B2. Recent studies using whole-genome sequencing analysis revealed 190 that ST131 consists of different lineages or clades: A/H41, B/H22, and C/H30; with the H 191 number which refers to the fimH allele which mostly corresponds to each clade (4, 23, 24).
192
Since the 2000s, clade C has become the most dominant lineage among ST131 isolates (7, 9) .
193
The clade C mainly consists of the fluoroquinolone resistant subclades C1 and C2 isolates, 194 with subclade C2 (also known as H30Rx) which is often associated with bla CTX-M-15 gene (4).
195
Recently, a C1 subclade associated with the bla CTX-M-27 gene, named C1-M27, has been 196 described on the Asian continent and also reported with an alarming increase in Europe. (6, 7, 197 25). The presence of 025b-H30x ST131 E. coli having CTX-M-27 was described in Tunisia 198 from human samples (14), and also from animal origin and wastewater (26) (14). By using this PCR procedure, we also showed that two E. community. The monitoring of these potential emergent clones is urgently needed, and 241 preventive programs to limit their dissemination should be implemented. were also searched by using a procedure described elsewhere (33, 34) . According results, 275 entire genes for selected strains were amplified and sequenced to identify bla CTX-M and bla NDM 276 subtypes using specific PCR primers known from their close genetic environment (35, 36) .
277
The custom-made DNA sequences (Eurofins) were analyzed using the Basic Local Alignment XbaI enzyme digestion and pulsed-field gel electrophoresis (PFGE) analysis using the CHEF 283 DRIII apparatus (Bio-Rad) as previously described (35). E. coli isolates were assigned to the 284 phylogenetic groups A, B1, B2, or D using a PCR strategy with specific primers for chuA, 285 yjaA, and TspE4.C2 determinants as reported elsewhere (37). Multilocus Sequence Typing 286 (MLST) was carried out for E. coli strains with similar pulsotypes and for the NDM-1-287 producing strain of K. pneumoniae. All the amplicons were sequenced and compared with the 288 sequences deposited in the MLST database to know the specific allele combination and the 289 sequence type (ST) for E. coli (http://enterobase.warwick.ac.uk/species/ecoli/allele_st_search) 290 and and K. pneumoniae (http://www.pasteur.fr/mlst/). Furthermore, we used the specific PCR We have no conflicts of interest to declare. -1 (lanes 1 to 4) ; E-3 and E-4 (lane 5 and 6, respectively); E-2 (lanes 7 and 8); 445 E-5 to E-11 (lanes 9 to 15, respectively). E. cloacae complex 0 (n=4) 0 (n=2) 0 (n=2) 0 (n=0) 0 (n=2) (a) , Number of ESBL-E (total strains number is indicated in parenthesis) 
